Epinephrine (Auvi-Q®)


Indications for Prior Authorization:

Emergency treatment of allergic reactions (Type 1) including anaphylaxis to stinging insects and biting insects, allergen immunotherapy, foods, drugs, diagnositc testing substances and other allergens, as well as idiopathic anaphylaxis or exericse-induced anaphylaxis.

Auvi-Q is intended for immediate self-administration as emergency supportive therapy only and is not a substitute for immediate medical care.

Patients must meet the following criteria for the indication(s) above:
  • Patients must try and fail preferred epinephrine products
  • Patients greater than or equal to 30kg: 0.3mg
  • Patients 15-30kg: 0.15mg
  • Patients 7.5-15kg: 0.1mg